A phase III clinical study exploring the use of Xarelto (rivaroxaban) in preventing strokes and embolism in recent stroke patients has been stopped because Xarelto showed no more efficacy than the current recommended care, low doses of aspirin, while also demonstrating higher bleeding rates than aspirin. Study “Stopping Early for... Read more »

GlaxoSmithKline is facing a Zofran lawsuit that contends the off-label morning sickness drug is dangerous to the developing fetus. The complaint is just one among many others containing similar allegations regarding the anti-nausea medication and birth defects. The case, filed in the US District Court for the District of New Jersey, demands... Read more »